【24h】

ASIA-PACIFIC

机译:亚太

获取原文
获取原文并翻译 | 示例
           

摘要

China Resources Group and Australia's Macouarie Group will use financing of about A$800m (US$598m) to back their acquisition of a stake of up to 74% in healthcare provider Genesis Care The financing, which includes term debt for the acquisition and revolving credit tranches for capital expenditure and working capital, has been provided by a group of banks and was funded on a club basis. It was initially designed to refinance outstanding debt in the event a sale did not materialise, but the banks have approved the use of the funds to back the acquisition. Financial close is expected in September, subject to a shareholder vote and approval from Australia's Foreign Investment Review Board Last week, the consortium signed the sale agreement, which includes acquiring private-equity giant KKR's 45% stake in the company. The acquisition valued Genesis Care - Australia's biggest cancer and cardiac care services provider - at an enterprise value of A$1.7bn. Reuters reported.
机译:华润集团和澳大利亚Macouarie集团将利用约8亿澳元(合5.98亿美元)的融资支持收购医疗保健提供商Genesis Care高达74%的股份。该融资包括收购的定期债务和循环信贷一部分银行提供了资本支出和营运资金的部分付款,并且是在俱乐部的基础上提供资金。它最初旨在在未实现出售的情况下对未偿债务进行再融资,但银行已批准使用这些资金来支持此次收购。上周,该财团签署了出售协议,其中包括收购私人股权投资巨头KKR在该公司45%的股份,预计该交易将于9月份结束,这要获得股东投票和澳大利亚外国投资审查委员会的批准。此次收购对澳大利亚最大的癌症和心脏保健服务提供商Genesis Care的估值为17亿澳元。路透社报道。

著录项

  • 来源
    《International Financing Review》 |2016年第2144期|58-62|共5页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号